Our data indicates that Vectus Biosystems Limited has a market capitalization of AU$45m, and total annual CEO compensation was reported as AU$230k for the year to June 2022. That is, the compensation ...

Vectus Biosystems seeks to raise up to $10 million to help develop its treatment for fibrosis and high blood pressure. A company developing a treatment that may reverse debilitating fibrosis is ...

Salary of AU$231.5k is part of CEO Karen Duggan's total remuneration The overall pay is 56% below the industry average Over the past three years, Vectus Biosystems' EPS grew by 21% and over the past ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Vectus Biosystems Limited has ...

Vectus Biosystems Limited (AU:VBS) has released an update. Vectus Biosystems Limited has announced an application for the quotation of 1,160 newly issued ordinary shares on the ASX under the code VBS, ...

Visit a quote page and your recently viewed tickers will be displayed here.

What is the current share price of Vectus Biosystems Limited (VBS)? Vectus Biosystems Limited's (VBS) current share price is $0.08. This constitutes a price movement of 0% when compared to the share ...